Skip to main content
Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

5. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2024. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed November 18, 2024.
  2. IMB Micromedex DRUGDEX (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu. Accessed November 19, 2024.
  3. Almotriptan (Axert) package insert. Ajanta Pharma Limited, March 2023.
  4. Eletriptan (Relpax) package insert. Viatris Specialty, LLC., January 2024.
  5. Frovatriptan package insert. Ingenus Pharmaceuticals, November 2023.
  6. Naratriptan package insert. Bionpharma, Inc., December 2023.
  7. Rizatriptan (Maxalt and Maxalt-MLT) package insert. Organon, LLC., June 2022.
  8. Sumatriptan tablets (Imitrex) package insert. GlaxoSmithKline, February 2024.
  9. Sumatriptan injection (Imitrex) package insert. GlaxoSmithKline, February 2023.
  10. Sumatriptan nasal spray (Imitrex) package insert. GlaxoSmithKline, March 2024.
  11. Sumatriptan nasal powder (Onzetra Xsail) package insert. Currax Pharmaceuticals, January 2024.
  12. Sumatriptan nasal spray (Tosymra) package insert. Upsher-Smith Laboratories, December 2023.
  13. Sumatriptan succinate injection (Zembrace SymTouch) package insert. Upsher-Smith Laboratories, January 2023.
  14. Zolmitriptan tablets (Zomig) package insert. Amneal Pharmaceuticals, LLC., February 2024.
  15. Zolmitriptan orally disintegrating tablets package insert. Alembic Pharmaceuticals, Inc., February 2024.
  16. Zolmitriptan nasal spray (Zomig) package insert. Amneal Pharmaceuticals, May 2019.
  17. Sumatriptan/naproxen tablets (Treximet) Package Insert. Currax Pharmaceuticals, LLC., February 2024.
  18. Winner P, Linder SL, Lipton RB, et al. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.  Headache. 2007;47(4):511-8.
  19. Ahonen K, Hamalainen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology. 2004;62:883-7.
  20. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000;106:989-97.
  21. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999;52:507-10.
  22. Hamalainen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults? Neurology. 1997;48(4):1100-3.
  23. Evers S, Rahmann A, Kraemer C, et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology. 2006;67:497-9.
  24. Rothner AD, Wasiewski W, Winner P, et al. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache. 2006;46:101-9.
  25. Winner P, Rothner AD, Wooten JD, et al. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache. 2006;46:212-22.
  26. Linder SL. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice. Headache. 1996;36(7):419-422. doi:10.1046/j.1526-4610.1996.3607419.x
  27. MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache. 1994;34(10):581-582. doi:10.1111/j.1526-4610.1994.hed3410581.x